UCSD finds genetic time bomb in heart that leads to heart failure in some patients

Each year, thousands of children undergo corrective surgery for congenital heart malformations that improve the immediate function of the heart. However, surgical correction of certain forms of congenital heart disease may not fix the underlying molecular trigger that drives progressive heart failure and sudden death later in life, according to new research from the University of California, San Diego (UCSD) School of Medicine. Over time, a genetic time bomb that causes structural abnormalities at birth, continues to degrade vital heart systems, eventually disrupting the electrical impulses that control the heartbeat.

Now, researchers have determined where and how this progressive heart failure occurs in patients with familial forms of congenital heart disease called atrial septal defects, even after the malformation is surgically corrected. The researchers believe that their findings could, potentially, apply to other forms of congenital heart disease, as well.

In a study published in the April 30 edition of the journal Cell, the investigators used mouse and human subjects to determine that genetic defects in a gene called Nkx2-5, which is critical for embryonic heart formation, continue to exert their detrimental effects over time by degrading the electrical wiring of the heart, in particular, the heart's atrioventricular (AV) node (which normally conducts electrical impulses between the upper and lower chambers of the heart), and by encouraging excessive overgrowth of heart tissue.

According to the March of Dimes, congenital heart defects, which are structural problems present at birth, are the most common birth defect in newborns. Atrial septal defects are sometimes called holes in the heart. A defect between the heart's two upper chambers (the atria) occurs in the septum, the wall that separates the heart's left and right sides. The most common treatment has been s

Contact: Sue Pondrom
University of California - San Diego

Page: 1 2 3 4

Related biology news :

1. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
2. DNA barcode finds four new bird species
3. Rice finds on-off switch for buckyball toxicity
4. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
5. South Dakota Tech grad student finds rare whale
6. Purdue study finds antioxidant protects metal-eating plants
7. Medication reconciliation, pharmacist involvement vital to reducing medication errors, study finds
8. Scientist who discovered Sly syndrome finds new research path to explore for treating the disease
9. Study finds anti-HIV protein evolved millions of years before the emergence of AIDS
10. Drug prevents chemotherapy-induced hearing loss, study finds
11. Old is young, study finds

Post Your Comments:

(Date:5/26/2020)... (PRWEB) , ... May 26, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, ... T-cell receptor (TCR)-mimetic bispecific T cell engagers and TCR-based therapeutics, has implemented ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... technology-based services specializing in background and medical screening, announces the launch of ... and keeping their workforce safe. The new service is provided by ClearStar’s ...
(Date:5/21/2020)... (PRWEB) , ... May 20, 2020 , ... ... and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health ... & Gene Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... May 05, 2020 , ... Smart Meter, a ... iGlucose® LTE Cat-M Cellular Connected Diabetes Blood Glucose Monitor and Remote ... newest and broadest cellular connectivity available, to provide patients with seamless connectivity to ...
(Date:4/22/2020)... BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) , ... ... ... headquartered in Budapest with US offices in Cambridge, MA, announced today that Omixon’s ... Meintjes led the early commercialisation of Omixon’s flagship product Holotype HLA since 2014 ...
(Date:4/7/2020)... Calif. (PRWEB) , ... April 06, 2020 , ... ... their future children, reached 200,000 SneakPeek Early Gender DNA Tests sold in ... SneakPeek was launched as an ecommerce product, where a mom could order her ...
(Date:4/1/2020)... Netherlands (PRWEB) , ... March ... ... Molecular Biology Systems, B.V. (MBS) has developed a method using its revolutionary ... to eight minutes. Combined with smaller reaction volumes, increased samples per run, ...
Breaking Biology Technology:
Cached News: